Relationship between expression of onco-related miRNAs and the endoscopic appearance of colorectal tumors

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2015, Pages 1526-1543

  Nakagawa, Yoshihito ^a   Akao, Yukihiro ^b   Taniguchi, Kohei ^b   Kamatani, Akemi ^a   Tahara, Tomomitsu ^a   Kamano, Toshiaki ^a   Nakano, Naoko ^a   Komura, Naruomi ^a   Ikuno, Hirokazu ^a   Ohmori, Takafumi ^a   Jodai, Yasutaka ^a   Miyata, Masahiro ^a   Nagasaka, Mistuo ^a   Shibata, Tomoyuki ^a   Ohmiya, Naoki ^a   Hirata, Ichiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Colorectal tumor; Endoscopic appearance; Microrna

Indexed keywords

MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 21; MICRORNA 34A; MICRORNA 7; UNCLASSIFIED DRUG;

ADENOMA; ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER MORPHOLOGY; COLORECTAL CANCER CELL LINE; COLORECTAL TUMOR; CONTROLLED STUDY; DOWN REGULATION; EARLY CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTESTINE ENDOSCOPY; LATERALLY SPREADING TUMOR GRANULAR TYPE; LATERALLY SPREADING TUMOR NON GRANULAR TYPE; ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; SPORADIC EXOPHYTIC ADENOMA; SPORADIC FLAT ELEVATED ADENOMA; UPREGULATION; CANCER STAGING; COLONOSCOPY; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOMA; CELL LINE, TUMOR; COLONOSCOPY; COLORECTAL NEOPLASMS; DOWN-REGULATION; HUMANS; MICRORNAS; NEOPLASM STAGING; UP-REGULATION;

EID: 84920973477     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16011526     Document Type: Article

References (43)

1. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75, 843–854.
2. Ambros, V. The functions of animal microRNAs. Nature 2004, 431, 350–355.
3. Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120, 15–20.
4. miRBase Home Page. Available online: http://www.mirbase.org (accessed on 1 October 2014).
5. Bartel, D.P.; Chen, C.Z. Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet 2004, 5, 396–400.
6. Lim, L.P.; Lau, N.C.; Garrett-Engele, P.; Grimson, A.; Schelter, J.M.; Castle, J.; Bartel, D.P.; Linsley, P.S.; Johnson, J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433, 769–773.
7. Kiriakidou, M.; Nelson, P.T.; Kouranov, A.; Fitziev, P.; Bouyioukos, C.; Mourelatos, Z.; Hatzigeorgiou, A. A combined computational experimental approach predicts human microRNA targets. Genes Dev. 2004, 18, 1165–1178.
8. Croce, C.M.; Calin, G.A. miRNAs, cancer, and stem cell division. Cell 2005, 122, 6–7.
9. Gregory, R.I.; Shiekhattar, R. MicroRNA biogenesis and cancer. Cancer Res. 2005, 65, 3509–3512.
10. Michael, M.Z.; O’Connor, S.M.; van Holst Pellekaan, N.G.; Young, G.P.; James, R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003, 1, 882–891.
11. Takagi, T.; Iio, A.; Nakagawa, Y.; Naoe, T.; Tanigawa, N.; Akao, Y. Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 2009, 77, 12–21.
12. Iio, A.; Nakagawa, Y.; Hirata, I.; Naoe, T.; Akao, Y. Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol. Cancer 2010, 9, 136–142.
13. Akao, Y.; Nakagawa, Y.; Hirata, I.; Iio, A.; Itoh, T.; Kojima, K.; Nakashima, R.; Kitade, Y.; Naoe, T. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010, 17, 398–408.
14. Akao, Y.; Noguchi, S.; Iio, A.; Kojima, K.; Takagi, T.; Naoe, T. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett. 2011, 300, 197–204.
15. Tuchiya, N.; Nakagama, H. MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis. Mutat. Res. 2010, 693, 94–100.
16. Schetter, A.J.; Leung, S.Y.; Sohn, J.J.; Zanetti, K.A.; Bowman, E.D.; Yanaihara, N.; Yuen, S.T.; Chan, T.L.; Kwong, D.L.; Au, G.K.; et al. MicroRNA expression profile associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299, 425–436.
17. Xiong, B.; Cheng, Y.; Ma, L.; Zhang, C. MiR-21 regulates biological behavior through the PTEN/PI-3K/Akt signaling pathway in human colorectal cancer cells. Int. J. Oncol. 2013, 42, 219–228.
18. Lu, Z.; Liu, M.; Stribinskis, V.; Klinge, C.M.; Ramos, K.S.; Colburn, N.H.; Li, Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27, 4373–4379.
19. Ahmed, F.E.; Ahmed, N.C.; Vos, P.W.; Bonnerup, C.; Atkins, J.N.; Casey, M.; Nuovo, G.J.; Naziri, W.; Wiley, J.E.; Mota, H.; et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics 2013, 10, 93–113.
20. Zhang, N.; Li, X.; Wu, C.W.; Dong, Y.; Cai, M.; Mok, M.T.; Wang, H.; Chen, J.; Ng, S.S.; Chen, M.; et al. MicroRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene 2013, 32, 5078–5088.
21. Minamoto, T.; Sawaguchi, K.; Mai, M.; Yamashita, N.; Sugimura, T.; Esumi, H. Infrequent K-Ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res. 1994, 54, 2841–2844.
22. Fujimori, T.; Satonaka, K.; Yamamura-Idei, Y.; Nagasako, K.; Maeda, S. Non-involvement of Ras mutations in flat colorectal adenomas and carcinomas. Int. J. Cancer 1994, 57, 51–55.
23. Shirai, H.; Ueno, E.; Osaki, M.; Tatebe, S.; Ito, H.; Kaibara, N. Expression of growth factor and their receptors in human early colorectal carcinomas: Immunohistochemical study. Anticancer Res. 1995, 15, 2889–2894.
24. Sada, M.; Mitomi, H.; Igarashi, M.; Katsumata, T.; Saigenji, K.; Okayasu, I. Cell kinetics, p53 and Bcl-2 expression, and c-Ki-Ras mutations in flat-elevated tubulovillous adenomas and adenocarcinomas of the colorectum: comparison with polypoid lesions. Scand. J. Gastroenterol. 1999, 34, 798–807.
25. Kudo, S.; Kashida, H.; Nakajima, T.; Tamura, S.; Nakajo, K. Endoscopic diagnosis and treatment of early colorectal cancer. World J. Surg. 1997, 21, 694–701.
26. Tamura, S.; Onishi, S. Laterally spreading colon cancer. N. Engl. J. Med. 2004, 351, e24.
27. Uraoka, T.; Saito, Y.; Matsuda, T.; Ikehara, H.; Gotoda, T.; Saito, D.; Fujii, T. Endoscopic indication for endoscopic mucosal resection of laterally spreading tumors in the colorectum. Gut 2006, 55, 1592–1597.
28. Mukawa, K.; Fujii, S.; Takeda, J.; Kitajima, K.; Tominaga, K.; Chibana, Y.; Fujita, M.; Ichikawa, K.; Tomita, S.; Ono, Y.; et al. Analysis of K-Ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors. J. Gastroenterol. Hepatol. 2005, 20, 1584–1590.
29. Hiraoka, S.; Kato, J.; Tatsukawa, M.; Harada, K.; Fujita, H.; Morikawa, T.; Shiraha, H.; Shiratori, Y. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-Ras mutations. Gastroenterology 2006, 131, 379–389.
30. Japanese Society for Cancer of the Colon and Rectum. In Japanese Classification of Colorectal Carcinoma, 8th ed.; Kanehara Shuppan: Tokyo, Japan, 2013.
31. Fearon, E.R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759–767.
32. Senda, T.; Shimomura, A.; Iizuka-Koga, A. Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene. Anatomical Sci. Int. 2005, 80, 121–131.
33. Kinzier, K.W.; Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 1996, 87, 159–170.
34. Jass, J.R. Do all colorectal carcinomas arise in preexisting adenomas? World J. Surg. 1989, 13, 45–51.
35. Muto, T.; Nagawa, H.; Watanabe, T.; Masaki, T.; Sawada, T. Colorectal carcinogenesis: Historical review. Dis. Colon Rectum 1997, 40, S80–S85.
36. Teixeira, C.R.; Tanaka, S.; Haruma, K.; Yoshihara, M.; Sumii, K.; Kajiyama, G.; Shimamoto, F. Flat-elevated colorectal neoplasms exhibit a high malignant potential. Oncology 1996, 53, 89–93.
37. Akao, Y.; Nakagawa, Y.; Kitade, Y.; Kinoshita, T.; Naoe, T. Down-regulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 2007, 98, 1914–1920.
38. Chen, Z.; Zeng, H.; Guo, Y.; Liu, P.; Pan, H.; Deng, A.; Hu, J. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-myc. J. Exp. Clin. Cancer Res. 2010, 29, 151.
39. English, J.M.; Pearson, G.; Baer, R.; Cobb, M.H. Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. J. Biol. Chem. 1998, 2, 73, 3854–3860.
40. Rothberg, P.G. The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli. Semin Surg. Oncol. 1987, 3, 152–158.
41. Hashimoto, K.; Nakagawa, Y.; Morikawa, H.; Niki, M.; Egashira, Y.; Hirata, I.; Katsu, K.; Akao, Y. Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines. Carcinogenesis 2001, 22, 1965–1970.
42. Mestdagh, P.; Hartmann, N.; Baeriswyl, L.; Andreasen, D.; Bernard, N.; Chen, C.; Cheo, D.; D’Andrade, P.; DeMayo, M.; Dennis, L.; et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat. Methods 2014, 11, 809–815.
43. Nakagawa, Y.; Iinuma, M.; Naoe, T.; Nozawa, Y.; Akao, Y. Characterized mechanism of α-mangostin-induced cell death: Caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg. Med. Chem. 2007, 15, 5620–5628.